These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 29259101

  • 1. Oncogenic PI3K promotes methionine dependency in breast cancer cells through the cystine-glutamate antiporter xCT.
    Lien EC, Ghisolfi L, Geck RC, Asara JM, Toker A.
    Sci Signal; 2017 Dec 19; 10(510):. PubMed ID: 29259101
    [Abstract] [Full Text] [Related]

  • 2. The glutamate/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility.
    Shin CS, Mishra P, Watrous JD, Carelli V, D'Aurelio M, Jain M, Chan DC.
    Nat Commun; 2017 Apr 21; 8():15074. PubMed ID: 28429737
    [Abstract] [Full Text] [Related]

  • 3. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy.
    Koppula P, Zhuang L, Gan B.
    Protein Cell; 2021 Aug 21; 12(8):599-620. PubMed ID: 33000412
    [Abstract] [Full Text] [Related]

  • 4. xCT knockdown in human breast cancer cells delays onset of cancer-induced bone pain.
    Ungard RG, Linher-Melville K, Nashed MG, Sharma M, Wen J, Singh G.
    Mol Pain; 2019 Aug 21; 15():1744806918822185. PubMed ID: 30799686
    [Abstract] [Full Text] [Related]

  • 5. Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells.
    Hasegawa M, Takahashi H, Rajabi H, Alam M, Suzuki Y, Yin L, Tagde A, Maeda T, Hiraki M, Sukhatme VP, Kufe D.
    Oncotarget; 2016 Mar 15; 7(11):11756-69. PubMed ID: 26930718
    [Abstract] [Full Text] [Related]

  • 6. ROS Mediate xCT-Dependent Cell Death in Human Breast Cancer Cells under Glucose Deprivation.
    Chen MC, Hsu LL, Wang SF, Hsu CY, Lee HC, Tseng LM.
    Cells; 2020 Jul 01; 9(7):. PubMed ID: 32630312
    [Abstract] [Full Text] [Related]

  • 7. Identification, Expression, and Roles of the Cystine/Glutamate Antiporter in Ocular Tissues.
    Martis RM, Knight LJ, Donaldson PJ, Lim JC.
    Oxid Med Cell Longev; 2020 Jul 01; 2020():4594606. PubMed ID: 32655769
    [Abstract] [Full Text] [Related]

  • 8. Redox-dependent AMPK inactivation disrupts metabolic adaptation to glucose starvation in xCT-overexpressing cancer cells.
    Lee Y, Itahana Y, Ong CC, Itahana K.
    J Cell Sci; 2022 Aug 01; 135(15):. PubMed ID: 35775474
    [Abstract] [Full Text] [Related]

  • 9. Signal transducer and activator of transcription 3 and 5 regulate system Xc- and redox balance in human breast cancer cells.
    Linher-Melville K, Haftchenary S, Gunning P, Singh G.
    Mol Cell Biochem; 2015 Jul 01; 405(1-2):205-21. PubMed ID: 25896132
    [Abstract] [Full Text] [Related]

  • 10. Structure, function, and regulation of human cystine/glutamate transporter in retinal pigment epithelial cells.
    Bridges CC, Kekuda R, Wang H, Prasad PD, Mehta P, Huang W, Smith SB, Ganapathy V.
    Invest Ophthalmol Vis Sci; 2001 Jan 01; 42(1):47-54. PubMed ID: 11133847
    [Abstract] [Full Text] [Related]

  • 11. The x(c)(-) cystine/glutamate antiporter (xCT) as a potential target for therapy of cancer: yet another cytotoxic anticancer approach?
    Savaskan NE, Hahnen E, Eyüpoglu IY.
    J Cell Physiol; 2009 Aug 01; 220(2):531-2; author reply 533-4. PubMed ID: 19415694
    [No Abstract] [Full Text] [Related]

  • 12. Stress-induced inhibition of nonsense-mediated RNA decay regulates intracellular cystine transport and intracellular glutathione through regulation of the cystine/glutamate exchanger SLC7A11.
    Martin L, Gardner LB.
    Oncogene; 2015 Aug 06; 34(32):4211-8. PubMed ID: 25399695
    [Abstract] [Full Text] [Related]

  • 13. Cystine/glutamate antiporter xCT deficiency reduces metastasis without impairing immune system function in breast cancer mouse models.
    Ruiu R, Cossu C, Iacoviello A, Conti L, Bolli E, Ponzone L, Magri J, Rumandla A, Calautti E, Cavallo F.
    J Exp Clin Cancer Res; 2023 Sep 29; 42(1):254. PubMed ID: 37770957
    [Abstract] [Full Text] [Related]

  • 14. The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate.
    Koppula P, Zhang Y, Shi J, Li W, Gan B.
    J Biol Chem; 2017 Aug 25; 292(34):14240-14249. PubMed ID: 28630042
    [Abstract] [Full Text] [Related]

  • 15. Increased expression of cystine/glutamate antiporter in multiple sclerosis.
    Pampliega O, Domercq M, Soria FN, Villoslada P, Rodríguez-Antigüedad A, Matute C.
    J Neuroinflammation; 2011 Jun 03; 8():63. PubMed ID: 21639880
    [Abstract] [Full Text] [Related]

  • 16. Transcriptional control of cystine/glutamate transporter gene by amino acid deprivation.
    Sato H, Nomura S, Maebara K, Sato K, Tamba M, Bannai S.
    Biochem Biophys Res Commun; 2004 Dec 03; 325(1):109-16. PubMed ID: 15522208
    [Abstract] [Full Text] [Related]

  • 17. A negative correlation between expression profiles of runt-related transcription factor-2 and cystine/glutamate antiporter xCT subunit in ovariectomized mouse bone.
    Uno K, Takarada T, Nakamura Y, Fujita H, Hinoi E, Yoneda Y.
    J Pharmacol Sci; 2011 Dec 03; 115(3):309-19. PubMed ID: 21325781
    [Abstract] [Full Text] [Related]

  • 18. Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer.
    Koppula P, Zhang Y, Zhuang L, Gan B.
    Cancer Commun (Lond); 2018 Apr 25; 38(1):12. PubMed ID: 29764521
    [Abstract] [Full Text] [Related]

  • 19. IGF-I regulates redox status in breast cancer cells by activating the amino acid transport molecule xC-.
    Yang Y, Yee D.
    Cancer Res; 2014 Apr 15; 74(8):2295-305. PubMed ID: 24686172
    [Abstract] [Full Text] [Related]

  • 20. A cystine-cysteine shuttle mediated by xCT facilitates cellular responses to S-nitrosoalbumin.
    Zhu J, Li S, Marshall ZM, Whorton AR.
    Am J Physiol Cell Physiol; 2008 Apr 15; 294(4):C1012-20. PubMed ID: 18287333
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.